Research programme: gene therapies - RhyGaze
Latest Information Update: 20 Feb 2025
At a glance
- Originator RhyGaze
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Retinal disorders
Most Recent Events
- 20 Feb 2025 Early research in Retinal disorders in Switzerland (Parenteral), before February 2025 (RhyGaze website, February 2025)